Table 1 Clinical characteristics of study patients
From: SLFN5 promotes reversible epithelial and mesenchymal transformation in ovarian cancer
| Â | All of data | EMT Data |
|---|---|---|
Case Load | 341 | 324 |
Neoplasm staging | ||
 Early phase | 29 (8.6) | 24 (7.5) |
 Later phase | 310 (91.4) | 298 (92.5) |
TNM stage | ||
 G1&G2 | 68 (20.4) | 67 (21.1) |
 G3&G4 | 265 (79.6) | 251 (78.9) |
 Age | 58.80 ± 11.13 | 58.73 ± 11.12 |
EMT | ||
 Epithelium | 178 (54.9) | 178 (54.9) |
 Mesenchyme | 146 (45.1) | 146 (45.1) |